​MetaSensor is the core technology behind ExoNostic’s approach to molecular fingerprinting. It is designed to capture a broad range of molecular signatures without relying on conventional methods that depend on specific markers such as antibodies, aptamers, or primers. This versatility allows MetaSensor to detect and analyze a wide array of biomolecules, providing deeper insights into biological systems.

By focusing on the holistic analysis of molecular interactions, MetaSensor offers a more complete picture of the molecular landscape, making it adaptable to various applications. Whether used for early-stage disease detection, monitoring environmental changes, or exploring new areas of biotechnology, MetaSensor provides an efficient and scalable solution for capturing and interpreting molecular data in real-time.

• Early Disease Detection: Identifying molecular changes at the earliest stages of disease development without the need for specific markers like antibodies or primers.

• Viral Vector Monitoring: Tracking viral vectors in gene therapy and vaccine development by analyzing the full spectrum of molecular interactions.

• Cancer Biomarker Analysis: Detecting and interpreting cancer-related molecular changes for more precise and comprehensive diagnostics.

• Environmental Monitoring: Assessing environmental samples for molecular contaminants, pathogens, or biomarkers of pollution.

• Pharmaceutical Research: Supporting drug development by analyzing molecular reactions and changes in response to treatments.

• Biotechnology Innovation: Enabling new biotechnological applications by providing a platform that adapts to various molecular discovery needs.